v3.26.3
Long-Term Investments (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2026
TWD ($)
shares
Oct. 31, 2021
USD ($)
shares
Sep. 30, 2025
shares
Sep. 30, 2026
USD ($)
shares
Sep. 30, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Long-Term Investments [Line Items]                
Percentage of ordinary shares         37.00%      
Aggregate amount | $         $ 7,000,000      
Prepayment for long-term investment | $         1,124,842   $ 1,124,842 [1]  
Disposition of long-term investment | $            
Common stock, shares authorized         100,000,000   100,000,000  
Ordinary shares issued and outstanding         26,841,266   25,053,193  
Payment to joint venture | $     $ 150,000          
Purchase additional shares (in Shares) 136,000 136,000            
BioFirst Corporation [Member]                
Long-Term Investments [Line Items]                
Ownership percentage         18.57%   18.68%  
Percentage of ordinary shares         18.57%   18.68%  
Aggregate amount | $               $ 2,688,578
Prepayment amount | $               $ 1,895,556
Converted shares (in Shares)               994,450
Prepayment for long-term investment | $         $ 1,124,842   $ 1,124,842  
Ordinary shares issued and outstanding     3,049          
Rgene Corporation (the “Rgene”) [Member]                
Long-Term Investments [Line Items]                
Percentage of ordinary shares         26.65%      
BioLite Japan K.K. [Member]                
Long-Term Investments [Line Items]                
Ownership percentage         49.00%   49.00%  
Percentage of ordinary shares     49.00%          
Common stock, shares authorized     10,000          
Payment to joint venture | $     $ 150,000          
BioLite JP [Member]                
Long-Term Investments [Line Items]                
Owned shares     1,494          
ForSeeCon Eye Corporation [Member]                
Long-Term Investments [Line Items]                
Ownership percentage         20.01%   19.78%  
Percentage of ordinary shares     51.00%          
Aggregate amount $ 680,000 $ 21,286,720            
ForSeeCon Eye Corporation [Member] | Vitargus [Member]                
Long-Term Investments [Line Items]                
Ownership percentage 0.46% 0.46%            
Common Stock [Member]                
Long-Term Investments [Line Items]                
Purchase additional shares (in Shares)       716,251 102,000 1,745,418    
Common Stock [Member] | Lucidaim Co Ltd Member [Member]                
Long-Term Investments [Line Items]                
Owned shares     1,555          
[1] Refer to Error Correction in Note 3.